A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosis.
Mult Scler. 2021 Dec;27(14):2240-2253. doi: 10.1177/13524585211003020. Epub 2021 Apr 6.
Mult Scler. 2021.
PMID: 33821693
Free PMC article.
Clinical Trial.